| abstract |
The present invention relates to compounds of formula (I), their pharmaceutically acceptable salts and tautomeric forms. The present invention also provides methods for preparing the compounds and their use as antidiabetic and hypoglycemic agents, alone or in combination with other antidiabetic agents such as sulfonylureas or biguanides, as well as hypertension, hyperuricemia or other It relates to its use in the treatment of complications associated with insulin resistance such as cardiovascular, metabolic and endocrine diseases or other diseases associated with diabetes. |